Clincosm LogoSign in Get a demo

parkinsonian syndrome

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) Trial in China (DaTSCAN™ Ioflupane (123I) Injection)

Completed
  • Parkinsonian Syndrome
  • +3 more
  • DaTSCAN™ Ioflupane (123I) Injection
  • Beijing, Chaoyang District, China
  • +9 more
Jun 20, 2022

Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy Trial in Phoenix (Complex eye movement

Completed
  • Parkinson Disease
  • +9 more
  • Complex eye movement exam
  • Phoenix, Arizona
    Dignity Health / St. Joseph's Hospital and Medical Center
May 3, 2022

Mitochondrial and Peroxisomal Metabolism to Differentiate

Recruiting
  • Idiopathic Parkinson Disease
  • Parkinsonian Syndrome
  • blood collection
  • Dijon, France
    Chu Dijon Bourgogne
Oct 26, 2021

Movement Disorders Analysis Using a Deep Learning Approach

Completed
  • Bradykinesia
  • +5 more
    • Bobigny, Seine Saint Denis, France
      Hospital Avicenne
    Jul 13, 2021

    Parkinson's Disease, Parkinsonian Syndrome Trial ([123I]ß-CIT and SPECT imaging)

    Completed
    • Parkinson's Disease
    • Parkinsonian Syndrome
    • [123I]ß-CIT and SPECT imaging
    • (no location specified)
    Apr 1, 2019

    Sense of Smell in Relatives of Parkinson's Disease Patients

    Completed
    • Parkinson Disease
    • Parkinsonian Syndrome
      • New Haven, Connecticut
        Institute for Neurodegenerative Disorders
      Apr 1, 2019

      Disclosing Imaging Study Information to Trial Participants

      Completed
      • Parkinsonian Syndrome
      • Parkinson
      • A series of questionnaires
      • New Haven, Connecticut
        Institute for Neurodegenerative Disorders
      Apr 1, 2019

      Transcranial Duplex Scanning and Single Photon Emission Computer

      Completed
      • Parkinson's Disease
      • +6 more
        • Maastricht, PO Box 5800, Netherlands
          Maastricht University Medical Center
        Feb 22, 2018

        Parkinsonian Syndrome Trial in New Haven ([123I]ß CIT)

        Completed
        • Parkinsonian Syndrome
        • [123I]ß CIT
        • New Haven, Connecticut
          Institute for Neurodegenerative Disorders
        Jul 14, 2014

        Parkinson Disease, Parkinsonian Syndrome Trial in New Haven ([123I]B-CIT)

        Completed
        • Parkinson Disease
        • Parkinsonian Syndrome
        • New Haven, Connecticut
          Institute for Neurodegenerative Disorders
        Apr 21, 2014

        Parkinson's Disease, Parkinsonian Syndrome Trial in New Haven ([123I]ß-CIT)

        Completed
        • Parkinson's Disease
        • Parkinsonian Syndrome
        • New Haven, Connecticut
          Institute for Neurodegenerative Disorders
        Apr 21, 2014

        Parkinsonian Syndrome Trial in New Haven ([123I]ß CIT and SPECT imaging)

        Completed
        • Parkinsonian Syndrome
        • [123I]ß CIT and SPECT imaging
        • New Haven, Connecticut
          Institute for Neurodegenerative Disorders
        Apr 9, 2014

        Individuals With Parkinson's Disease

        Completed
        • Parkinson's Disease
        • Parkinsonian Syndrome
        • Automated Neuropsychological Assessment Matrix
        • New Haven, Connecticut
          Institute for Neurodegenerative Disorders
        Feb 8, 2012

        Parkinson Disease, Parkinsonian Syndrome Trial in United States (levodopa, Mirapex (pramipexole), [123I]ß-CIT and SPECT imaging)

        Completed
        • Parkinson Disease
        • Parkinsonian Syndrome
        • Oxnard, California
        • +12 more
        Sep 28, 2010

        Parkinson Disease, Parkinsonian Syndrome Trial in Worldwide (cabergoline, carbidopa/levodopa, DATscan and SPECT imaging)

        Completed
        • Parkinson Disease
        • Parkinsonian Syndrome
        • Innsbruck, Austria
        • +8 more
        Aug 27, 2009